Diseases of Pulmonary Vasculature

Latest News

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

VTE Recurrence Risk Reduced With Rivaroxaban: Q&A With EINSTEIN CHOICE Investigator

Results from the EINSTEIN CHOICE trial plus an interview with investigator Philip Stephen Wells, MD, FRCP(C), MSc.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Case Study: Worsening Leg Edema And Shortness Of Breath In Urgent Care

A man presents to an urgent care clinic with gradually progressive leg edema and shortness of breath.

Statin Use May Reduce Mortality in COPD Patients

Statin Use May Reduce Mortality in COPD Patients

While data are conflicting, statin use in COPD may help reduce pulmonary-related and all-cause mortality.

Intracerebral Hemorrhage: Trends in Medical Complications

Intracerebral Hemorrhage: Trends in Medical Complications

After intracerebral hemorrhage, both acute renal failure and deep venous thrombosis have increased.

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

Pulmonary Arterial Hypertension and Genetics: Interview With the Experts

James E. Loyd, MD, and Wendy Chung, MD, PhD, offer insight into the role of genetics in pulmonary arterial hypertension.

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

How Does Pulmonary Embolism Risk Compare After CVT vs DVT?

Pulmonary embolism risk after cerebral venous thromboembolism is significantly lower than after deep vein thromboembolism.

Pulmonary Embolism Adverse Events for Outpatients vs Inpatients

Pulmonary Embolism Adverse Events for Outpatients vs Inpatients

Outpatient treatment of hemodynamically stable pulmonary embolism appeared to be associated with lower rates of adverse events.

Dosing Strategy and Bleeding Risk in VTE: Is Less Frequent Injection Better?

Dosing Strategy and Bleeding Risk in VTE: Is Less Frequent Injection Better?

Patients who took enoxaparin once daily had few major bleeds compared with patients who took enoxaparin twice daily.

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Venous Thromboembolism Risk Increased With Giant Cell Arteritis

Patients with giant cell arteritis were more likely to experience venous thromboembolism during the first 3 months following diagnosis.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Treatments

Initial combination therapy with ambrisentan and tadalafil reduced the risk for first clinical failure event in patients with connective tissue disease-associated pulmonary arterial hypertension.

Sleep Apnea Increases Risk of Recurrent Pulmonary Embolism

Sleep Apnea Increases Risk of Recurrent Pulmonary Embolism

Obstructive sleep apnea is an independent risk factor for recurrent pulmonary embolism in patients who stop taking oral anticoagulation for a first episode.

Pulmonary Embolism as a Differential Diagnosis to Syncope

Pulmonary Embolism as a Differential Diagnosis to Syncope

About 17% of patients hospitalized for a first episode of syncope has a pulmonary embolism.

Sleep Apnea Increases Risk for Complications After Surgery

Sleep Apnea Increases Risk for Complications After Surgery

Obstructive sleep apnea may increase the risk of postoperative atrial fibrillation and venous thromboembolism.

Resistant Hypertension May Increase Sleep Apnea Risk

Resistant Hypertension May Increase Sleep Apnea Risk

Patients with resistant hypertension had a modest increase in risk of developing sleep apnea compared to those with nonresistant hypertension.

Pulmonary Embolism Diagnostic Testing Methods: Wells Rule vs "Gestalt"

Pulmonary Embolism Diagnostic Testing Methods: Wells Rule vs "Gestalt"

Gestalt had a failure rate of 1.3% with an efficiency of 25% vs the Wells rule which had a failure rate of 1.5% but an efficiency of 45% in safely ruling out pulmonary embolism.

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

New Metabolites Associated With Hemodynamic Indicators of Right Ventricular-Pulmonary Vascular Dysfunction Discovered

Researchers discovered 21 new metabolites associated with 2 or more hemodynamic indicators of right ventricular-pulmonary vascular function.

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

Treatment and Length of Stay Changes Reduce Pulmonary Embolism Mortality

RIETE registry reveals an association between improved hospital care and reduced pulmonary embolism mortality.

Cholesterol-Dependent Protein Implicated in Sleep Apnea Reversed With Statins

Cholesterol-Dependent Protein Implicated in Sleep Apnea Reversed With Statins

Protein CD59, a major complement inhibitor that protects endothelial cells from membrane attack complex, has been implicated in sleep apnea--the effects of which were reduced with statins.

FDA Approved Selexipag for Pulmonary Arterial Hypertension

FDA Approved Selexipag for Pulmonary Arterial Hypertension

Selexipag, an oral IP prostacyclin receptor agonist, has been approved by the FDA to treat adults with pulmonary arterial hypertension.

Sign Up for Free e-Newsletters